A small study has found that a weekly intravenous dose may be effective in reducing concentrations of parathyroid hormone. 칼시트리올에 비해 파리칼시톨의 장점은 과거 연구에서 확인된 바 있습니다. In approximately patients having haemodialysis the mortality rate was.